Access to CAR T-cell therapy: Focus on diversity, equity and inclusion
{{output}}
Chimeric antigen receptor T-cell (CAR T-cell) therapy has revolutionized the treatment of hematologic malignancies in patients with relapsed or refractory disease without other treatment options. However, only a very small proportion of patients with an indica... ...
